Cytoprotective Effects of Hydrogen Sulfide in Novel Rat Models of Non-Erosive Esophagitis
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index; 15 of the 53 sources its claims cite were checked for support.
Abstract
Non-erosive esophagitis is a chronic inflammatory condition of the esophagus and is a form of gastroesophageal reflux disease. There are limited treatment options for non-erosive esophagitis, and it often progresses to Barrett's esophagus and esophageal carcinoma. Hydrogen sulfide has been demonstrated to be a critical mediator of gastric and intestinal mucosal protection and repair. However, roles for H2S in esophageal mucosal defence, inflammation and responses to injury have not been reported. We therefore examined the effects of endogenous and exogenous H2S in rat models of non-erosive esophagitis. Mild- and moderate-severity non-erosive esophagitis was induced in rats through supplementation of drinking water with fructose, plus or minus exposure to water-immersion stress. The effects of inhibitors of H2S synthesis or of an H2S donor on severity of esophagitis was then examined, along with changes in serum levels of a pro- and an anti-inflammatory cytokine (IL-17 and IL-10, respectively). Exposure to water-immersion stress after consumption of the fructose-supplemented water for 28 days resulted in submucosal esophageal edema and neutrophil infiltration and the development of lesions in the muscular lamina and basal cell hyperplasia. Inhibition of H2S synthesis resulted in significant exacerbation of inflammation and injury. Serum levels of IL-17 were significantly elevated, while serum IL-10 levels were reduced. Treatment with an H2S donor significantly reduced the severity of esophageal injury and inflammation and normalized the serum cytokine levels. The rat models used in this study provide novel tools for studying non-erosive esophagitis with a range of severity. H2S contributes significantly to mucosal defence in the esophagus, and H2S donors may have therapeutic value in treating esophageal inflammation and injury.
Overview
CoChat Summary
## TL;DR
This rat study found that reducing endogenous hydrogen sulfide (H2S) worsened non-erosive esophagitis, while giving an H2S donor reduced esophageal injury and inflammation. The effect tracked with serum cytokines: IL-17 rose and IL-10 fell with worse disease, and the opposite pattern was seen with H2S treatment.
## Key findings
- In healthy rats, inhibiting H2S synthesis caused only mild esophageal inflammation, with histological scores of 1–2 on a 0–9 scale, but no detectable mucosal damage.
- In the fructose-induced hyperglycemia model, blood glucose increased from 5.8±0.2 to 6.4±0.2 mmol/L (p<0.05) and body weight increased by 8–10% versus controls; esophagitis severity increased and was worsened by PAG but not CHH.
- In the hyperglycemia + water-immersion stress model, PAG again significantly increased severity, while NaHS significantly reduced esophagitis; L-Trp also reduced damage and, with NaHS, dramatically reduced histological changes and prevented hemorrhagic changes observed with PAG alone.
- Across models, worse esophagitis was accompanied by higher IL-17 and lower IL-10; PAG or CHH decreased IL-10 and increased IL-17, while NaHS had the opposite effects.
## Methods
- Rat experimental study using male Wistar rats (180–220 g), with 6–7 rats per group; animals were fasted 18 h before experiments and anesthetized with ketamine.
- Two novel non-erosive esophagitis models were used: fructose-water for 28 days to induce hyperglycemia, and a more severe model combining hyperglycemia with 3.5 h water-immersion stress at 23°C.
- Rats received vehicle, PAG (25 mg/kg), CHH (20 mg/kg), NaHS (100 µmol/kg), or L-Trp (50 mg/kg); esophageal injury was scored histologically and serum IL-10/IL-17 were measured by ELISA, with group comparisons by t-test or one-way ANOVA + Newman-Keuls.
## Limitations
- Not stated in the paper.
- Evident from the text: this is an animal study, so the findings may not directly translate to humans with non-erosive reflux disease.
- Evident from the text: the study tested acute/short-term interventions and histological/cytokine outcomes, not long-term clinical endpoints.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
10 Valid · 5 Not valid · 13 Not checked · 43 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“In addition, the conventional treatment for non-erosive reflux disease with gastric acid suppressing medications has been associated with an increased incidence of abnormal microbiota and malignancy [10].”
§ Cytoprotective Effects of Hydrogen Sulfide in Novel Rat Models of Non-Erosive Esophagitis > Introduction
What the sources say
- Disputedcites [10] KL Blackett, 2013, Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality?, Alimentary Pharmacology & Therapeutics sourceExperimental — accuracy not yet measured
The Demographics section (page unavailable) reports no microbiological difference between patients prescribed PPIs and those not prescribed them. The Real-time PCR analysis likewise found no statistically significant difference by PPI exposure. The paper discusses microbiota changes with reflux-related disease, but does not link acid-suppressing treatment to increased malignancy. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Indeed, experimental long-term postprandial hyperglycemia contributes to impairment of the esophageal barrier function [3], .”
§ Cytoprotective Effects of Hydrogen Sulfide in Novel Rat Models of Non-Erosive Esophagitis > Introduction
What the sources say
- Partly supportedcites [3] R Promberger, 2014, Gastro-oesophageal reflux disease in type 2 diabetics: symptom load and pathophysiologic aspects - a retro-pro study, BMC Gastroenterology sourceExperimental — accuracy not yet measured
The Background reports that hyperglycaemia has been associated with reduced lower oesophageal sphincter pressure and more transient relaxations, which could impair the barrier against reflux. But the paper does not establish this for experimental, long-term postprandial hyperglycaemia; its Discussion says its own diabetic patients had higher sphincter pressure than non-diabetic patients (page unavailable in our copy). (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Postprandial hyperglycemia is a risk factor for acid reflux and the development of non-erosive esophagitis.”
§ Cytoprotective Effects of Hydrogen Sulfide in Novel Rat Models of Non-Erosive Esophagitis > Introduction
What the sources say
- Could not verifycites [2] IM Modlin, 2009, Diagnosis and management of non-erosive reflux disease–the Vevey NERD Consensus Group, Digestion sourceExperimental — accuracy not yet measured
The section on weakly acidic reflux discusses acid exposure and symptom generation in NERD, but not postprandial blood glucose. Searches for postprandial hyperglycemia, glucose and diabetes found no passage linking elevated blood glucose to acid reflux or the development of non-erosive esophagitis; the paper instead identifies hiatus hernia as a risk factor for esophagitis. (LLM, conf=0.75)
- Not checked — no full text of the sourcecites [17] O Zayachkivska, 2008, Effects of nitrosative stress and reactive oxygen-scavenging systems in esophageal physiopathy under streptozotocin-induced experimental hyperglycemia, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These doses of PAG and CHH have been shown to significantly inhibit CSE and CBS activities in rats [34], [35].”
§ Cytoprotective Effects of Hydrogen Sulfide in Novel Rat Models of Non-Erosive Esophagitis > Materials and Methods > Role of Hydrogen Sulfide
What the sources say
- Not checked — no full text of the sourcecites [34] JL Wallace, 2007, Hydrogen sulfide enhances ulcer healing in rats, FASEB J source
- Partly supportedcites [35] JL Wallace, 2009, Endogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats, Gastroenterology sourceExperimental — accuracy not yet measured
The Effects of Inhibitors section (page unavailable) identifies PAG as a CSE inhibitor and CHH as a CBS inhibitor, and reports testing them on rat colonic tissue. But the Figure 3 caption (page unavailable) says that, at 3 mmol/L, only CHH significantly reduced H₂S synthesis in healthy tissue; it does not show significant inhibition by PAG at that concentration. The reported endpoint was H₂S synthesis in tissue, not a direct measurement of both enzyme activities after dosing rats. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Several animal and human studies suggest that this is responsible for initiating esophageal mucosal injury and the development of dysmotility [13], [18], [19].”
§ Cytoprotective Effects of Hydrogen Sulfide in Novel Rat Models of Non-Erosive Esophagitis > Introduction
What the sources say
- Not checked — no full text of the sourcecites [13] T Nishida, 2004, Gastroesophageal reflux disease related to diabetes: Analysis of 241 cases with type 2 diabetes mellitus, Journal of Gastroenterology and Hepatology source
- Not checked — no full text of the sourcecites [18] JD Soderholm, 2007, Stress-related changes in oesophageal permeability: filling the gaps of GORD?, Gut source
- Could not verifycites [19] YC Wu, 2012, Hydrogen sulfide lowers proliferation and induces protective autophagy in colon epithelial cells, PLoS One sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) concerns hydrogen sulfide and colon epithelial cells, not postprandial hyperglycemia or esophageal injury. Searches for the claim’s distinctive terms and for esophageal motility found no passage in our copy addressing that proposed relationship. (LLM, conf=0.78)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
28 more claims · 2 with their cited sources checked
Create a free account to see all 71 claims and to verify the 4 references still open.
- Probably not a substantial claim. 17
- It may state two separate claims as one. 29
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Cytoprotective Effects of Hydrogen Sulfide in Novel Rat Models of Non-Erosive Esophagitis > Results > Inhibition of H2S Synthesis Caused Mild Esophageal Inflammation in Healthy Rats
“Treatment with PAG and CHH both resulted in significant decreases in serum IL-10 and increases in IL-17 (Fig. 1).”
§ Cytoprotective Effects of Hydrogen Sulfide in Novel Rat Models of Non-Erosive Esophagitis > Discussion
“Inhibition of H2S synthesis was also associated with marked increases in serum levels of IL-10 (an anti-inflammatory cytokine) and decreased serum levels of IL-17 (a pro-inflammatory cytokine), while the H2S donor had the opposite effect.”
Citations
Cites
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
Wang, R. (2012) · Physiological Reviews · doi:10.1152/physrev.00017.2011 · Cited by 1,939 · cited 1×
“Endogenous H2S is produced from L-cysteine, with the enzymes cystathionine c-lyase (CSE) and cystathionine b-synthase (CBS) representing two of the major pathways [31–33].”
BackgroundHydrogen sulfide is an endogenous stimulator of angiogenesis
Papapetropoulos, A., Pyriochou, A., Altaany, Z., Yang, G., Marazioti, A., Zhou, Z., Jeschke, M. G., Branski, L. K., Herndon, D. N., Wang, R., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908047106 · Cited by 862 · cited 1×
“Accleration of ulcer healing is most likely related to the ability of H2S to promote angiogenesis [30,39], while prevention of tissue injury may be related to the ability of H2S to maintain mucosal blood flow [29,38], stimulate bicarbonate secretion [40,41], stimulate mucus secretion [42], inhibit leukocyte adherence…”
BackgroundHydrogen sulfide is an endogenous modulator of leukocyte‐mediated inflammation
Zanardo, R. C. O., Brancaleone, V., Distrutti, E., Fiorucci, S., Cirino, G., Wallace, J. L., Zanardo, R. C. O., Brancaleone, V., Distrutti, E., Fiorucci, S., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-6270fje · Cited by 859 · cited 1×
“Accleration of ulcer healing is most likely related to the ability of H2S to promote angiogenesis [30,39], while prevention of tissue injury may be related to the ability of H2S to maintain mucosal blood flow [29,38], stimulate bicarbonate secretion [40,41], stimulate mucus secretion [42], inhibit leukocyte adherence…”
BackgroundSelf-citationHydrogen Sulfide Increases Glutathione Production and Suppresses Oxidative Stress in Mitochondria
Kimura, Y., Goto, Y.-I., & Kimura, H. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2282 · Cited by 685 · cited 1×
“Accleration of ulcer healing is most likely related to the ability of H2S to promote angiogenesis [30,39], while prevention of tissue injury may be related to the ability of H2S to maintain mucosal blood flow [29,38], stimulate bicarbonate secretion [40,41], stimulate mucus secretion [42], inhibit leukocyte adherence…”
BackgroundGoldberg, R. B. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2534 · Cited by 644
Hymowitz, S. G., Filvaroff, E. H., Yin, J., Lee, J., Cai, L., Risser, P., Maruoka, M., Mao, W., Foster, J., Kelley, R. F., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.19.5332 · Cited by 548 · cited 1×
“Suppression of IL-8 production in keratinocytes by H2S has been reported to be a consequence of diminished IL-17 production, as IL-17 can induce IL-8 production [51,52].”
BackgroundFiorucci, S., Antonelli, E., Distrutti, E., Rizzo, G., Mencarelli, A., Orlandi, S., Zanardo, R., Renga, B., Di Sante, M., Morelli, A., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.07.060 · Cited by 410 · cited 2×
“Accleration of ulcer healing is most likely related to the ability of H2S to promote angiogenesis [30,39], while prevention of tissue injury may be related to the ability of H2S to maintain mucosal blood flow [29,38], stimulate bicarbonate secretion [40,41], stimulate mucus secretion [42], inhibit leukocyte adherence…”
BackgroundSelf-citationAsimakopoulou, A., Panopoulos, P., Chasapis, C. T., Coletta, C., Zhou, Z., Cirino, G., Giannis, A., Szabo, C., Spyroulias, G. A., & Papapetropoulos, A. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12171 · Cited by 393
Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative
Li, L., Rossoni, G., Sparatore, A., Lee, L. C., Del Soldato, P., & Moore, P. K. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.12.011 · Cited by 345
Hydrogen sulfide-releasing anti-inflammatory drugs
Wallace, J. L. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.09.003 · Cited by 328 · cited 3×
“Accleration of ulcer healing is most likely related to the ability of H2S to promote angiogenesis [30,39], while prevention of tissue injury may be related to the ability of H2S to maintain mucosal blood flow [29,38], stimulate bicarbonate secretion [40,41], stimulate mucus secretion [42], inhibit leukocyte adherence…”
BackgroundSelf-citationEndogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats
Wallace, J. L., Vong, L., McKnight, W., Dicay, M., & Martin, G. R. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.012 · Cited by 308 · cited 1×
“Suppression of endogenous H2S synthesis has been shown to impair gastric and colonic mucosal defence, and to impair healing of ulcers [26,27,34,35].”
BackgroundSelf-citationHydrogen Sulfide Is a Signaling Molecule and a Cytoprotectant
Kimura, H., Shibuya, N., & Kimura, Y. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4345 · Cited by 291 · cited 1×
“Endogenous H2S is produced from L-cysteine, with the enzymes cystathionine c-lyase (CSE) and cystathionine b-synthase (CBS) representing two of the major pathways [31–33].”
BackgroundWallace, J. L., Caliendo, G., Santagada, V., Cirino, G., & Fiorucci, S. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.042 · Cited by 271
Self-citationHydrogen sulfide enhances ulcer healing in rats
Wallace, J. L., Dicay, M., McKnight, W., & Martin, G. R. (2007) · The FASEB Journal · doi:10.1096/fj.07-8669com · Cited by 236 · cited 3×
“Suppression of endogenous H2S synthesis has been shown to impair gastric and colonic mucosal defence, and to impair healing of ulcers [26,27,34,35].”
BackgroundSelf-citationMarkedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346)
Wallace, J. L., Caliendo, G., Santagada, V., & Cirino, G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00611.x · Cited by 231 · cited 1×
“Suppression of endogenous H2S synthesis has been shown to impair gastric and colonic mucosal defence, and to impair healing of ulcers [26,27,34,35].”
BackgroundSelf-citationFiorucci, S., Orlandi, S., Mencarelli, A., Caliendo, G., Santagada, V, Distrutti, E., Santucci, L., Cirino, G., & Wallace, J. L. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707193 · Cited by 214
Self-citationBlackett, K. L., Siddhi, S. S., Cleary, S., Steed, H., Miller, M. H., Macfarlane, S., Macfarlane, G. T., & Dillon, J. F. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12317 · Cited by 211 · cited 1×
“In addition, the conventional treatment for non-erosive reflux disease with gastric acid suppressing medications has been associated with an increased incidence of abnormal microbiota and malignancy [10].”
BackgroundStudies on the drugs for peptic ulcer. A reliable method for producing stress ulcer in rats
Takagi, K., Kasuya, Y., & Watanabe, K. (1964) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.12.465 · Cited by 208 · cited 2×
“[37] that involves short-term exposure to water-immersion stress.”
BackgroundSavarino, E., Zentilin, P., Mastracci, L., Dulbecco, P., Marabotto, E., Gemignani, L., Bruzzone, L., de Bortoli, N., Frigo, A. C., Fiocca, R., et al. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-012-0672-2 · Cited by 181 · cited 1×
“being identified as the most pernicious cancer of the gastrointestinal tract, have sharply risen in incidence over the last decade [9,13].”
BackgroundRole of nitrosative stress in the pathogenesis of diabetic vascular dysfunction
Szabo, C. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00086.x · Cited by 165 · cited 1×
“This impairment includes esophageal ischemia and hypoxia secondary to microvascular changes and peroxynitrite-mediated endothelial and enteric neuron damage [24,25].”
BackgroundAnti-Inflammatory and Cytoprotective Actions of Hydrogen Sulfide: Translation to Therapeutics
Wallace, J. L., Blackler, R. W., Chan, M. V., Da Silva, G. J., Elsheikh, W., Flannigan, K. L., Gamaniek, I., Manko, A., Wang, L., Motta, J.-P., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.5901 · Cited by 156
Self-citationDiagnosis and management of non-erosive reflux disease–the Vevey NERD Consensus Group
Modlin, I. M., Hunt, R. H., Malfertheiner, P., Moayyedi, P., Quigley, E. M., Tytgat, G. N. J., Tack, J., Heading, R. C., Holtman, G., & Moss, S. F. (2009) · Digestion · doi:10.1159/000219365 · Cited by 154
Reactive oxygen species and the control of vascular function
Wolin, M. S. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01167.2008 · Cited by 133 · cited 1×
“It has been proposed that post-prandial hyperglycemia initiates a shift in redox systems, characterized by cellular membrane injury by free radicals, as well as reduced circulating homocysteine levels [56].”
BackgroundHydrogen sulfide lowers proliferation and induces protective autophagy in colon epithelial cells
Wu, Y. C., Wang, X. J., Yu, L., Chan, F. K. L., Cheng, A. S. L., Yu, J., Sung, J. J. Y., Wu, W. K. K., & Cho, C. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037572 · Cited by 109 · cited 1×
“esophageal mucosal injury and the development of dysmotility [13,18,19].”
BackgroundChan, M. V., & Wallace, J. L. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00169.2013 · Cited by 98
Self-citationFlannigan, K. L., Agbor, T. A., Blackler, R. W., Kim, J. J., Khan, W. I., Verdu, E. F., Ferraz, J. G. P., & Wallace, J. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413390111 · Cited by 97
Self-citationDufton, N., Natividad, J., Verdu, E. F., & Wallace, J. L. (2012) · Scientific Reports · doi:10.1038/srep00499 · Cited by 95 · cited 1×
“Accleration of ulcer healing is most likely related to the ability of H2S to promote angiogenesis [30,39], while prevention of tissue injury may be related to the ability of H2S to maintain mucosal blood flow [29,38], stimulate bicarbonate secretion [40,41], stimulate mucus secretion [42], inhibit leukocyte adherence…”
BackgroundSelf-citationGastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence
Blackler, R., Syer, S., Bolla, M., Ongini, E., & Wallace, J. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035196 · Cited by 93
Self-citationHydrogen Sulfide and Endothelial Dysfunction: Relationship with Nitric Oxide
Altaany, Z., Moccia, F., Munaron, L., Mancardi, D., & Wang, R. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140706142930 · Cited by 86 · cited 1×
“H2S has been implicated as a regulator of both nitric oxide and eicosanoid ynthesis [28,34,60].”
BackgroundNSAID-gastroenteropathy: new aspects of pathogenesis and prevention
Blackler, R. W., Gemici, B., Mańko, A., & Wallace, J. L. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.05.008 · Cited by 81
Self-citationGastroesophageal reflux disease–from reflux episodes to mucosal inflammation
Kandulski, A., & Malfertheiner, P. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.210 · Cited by 76 · cited 1×
“According to a recent study, gastric acid is a strong activator a number of autoprotective mechanisms, including proliferation and differentiation, as well as the production of anti-inflammatory cytokines, growth factors and endogenous antioxidants [4,11,12].”
BackgroundSulfide Enhancement of Pmn Apoptosis
Mariggiò, M. A., Minunno, V., Riccardi, S., Santacroce, R., Rinaldis, P. D., & Fumarulo, R. (1998) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923979809034822 · Cited by 73 · cited 1×
“Accleration of ulcer healing is most likely related to the ability of H2S to promote angiogenesis [30,39], while prevention of tissue injury may be related to the ability of H2S to maintain mucosal blood flow [29,38], stimulate bicarbonate secretion [40,41], stimulate mucus secretion [42], inhibit leukocyte adherence…”
BackgroundFlannigan, K. L., Ferraz, J. G. P., Wang, R., & Wallace, J. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071962 · Cited by 72
Self-citationMard, S. A., Neisi, N., Solgi, G., Hassanpour, M., Darbor, M., & Maleki, M. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2051-5 · Cited by 67
NISHIDA, T., TSUJI, S., TSUJII, M., ARIMITSU, S., SATO, T., HARUNA, Y., MIYAMOTO, T., KANDA, T., KAWANO, S., & HORI, M. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2003.03288.x · Cited by 65 · cited 3×
“The models of esophagitis used combined two elements known to contribute to esophageal injury: hyperglycemia [36] and exposure to restraint-stress [13,37].”
BackgroundMastrocola, R., Collino, M., Rogazzo, M., Medana, C., Nigro, D., Boccuzzi, G., & Aragno, M. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00450.2012 · Cited by 63 · cited 1×
“According to a recent study, gastric acid is a strong activator a number of autoprotective mechanisms, including proliferation and differentiation, as well as the production of anti-inflammatory cytokines, growth factors and endogenous antioxidants [4,11,12].”
BackgroundTherapy Insight: gastrointestinal complications of diabetes-pathophysiology and management
Sellin, J. H., & Chang, E. B. (2008) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1054 · Cited by 59 · cited 1×
“Moreover many metabolic disorders and diet-related chronic diseases appear to play key roles in the pathogenesis of GERD and non-erosive reflux disease [17,20,21].”
BackgroundHydrogen sulfide inhibits IL-8 expression in human keratinocytes via MAP kinase signaling
Mirandola, P., Gobbi, G., Micheloni, C., Vaccarezza, M., Marcantonio, D. D., Ruscitti, F., Panfilis, G. D., & Vitale, M. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.76 · Cited by 57
(2007) · PubMed · Cited by 46
Self-citationEsophageal function worsens with long duration of diabetes
Kinekawa, F., Kubo, F., Matsuda, K., Kobayashi, M., Furuta, Y., Fujita, Y., Okada, H., Muraoka, T., Yamanouchi, H., Inoue, H., et al. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-008-2169-6 · Cited by 42 · cited 1×
“These concerns highlight the importance of better understanding the pathogenesis of GERD and identifying effective means of preventing and treating this disorder [5,21].”
BackgroundRegional susceptibility to stress-induced intestinal injury in the mouse
Novosad, V. L., Richards, J. L., Phillips, N. A., King, M. A., & Clanton, T. L. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00166.2013 · Cited by 38 · cited 1×
“Indeed, several important advances have been made with respect to understanding the early biochemical and molecular mechanisms of ulceration and healing in other parts of the GI tract [12,14–16].”
BackgroundGas Mediators Involved in Modulating Duodenal HCO3- Secretion
Takeuchi, K., Aihara, E., Kimura, M., et al. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803413962 · Cited by 35
Wu, P., Ma, L., Dai, G. X., Chen, Y., Tong, Y. L., Wang, C., Yao, L. W., Jiang, Y. X., Xu, S. C., & Ai, Z. S. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01786.x · Cited by 32 · cited 2×
“These concerns highlight the importance of better understanding the pathogenesis of GERD and identifying effective means of preventing and treating this disorder [5,21].”
BackgroundPromberger, R., Lenglinger, J., Riedl, O., Seebacher, G., Eilenberg, W. H., Ott, J., Riegler, F. M., Gadenstätter, M., & Neumayer, C. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-132 · Cited by 31 · cited 11×
“These concerns highlight the importance of better understanding the pathogenesis of GERD and identifying effective means of preventing and treating this disorder [5,21].”
BackgroundInfluentialEffect of hyperglycemia on triggering of transient lower esophageal sphincter relaxations
Zhang, Q., Horowitz, M., Rigda, R., Rayner, C., Worynski, A., & Holloway, R. H. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00383.2003 · Cited by 30 · cited 3×
“Hyperglycemia triggers relaxation of the lower esophageal sphincter [55], thereby promoting acid reflux.”
BackgroundStress-related changes in oesophageal permeability: filling the gaps of GORD?: Figure 1
Söderholm, J. D. (2007) · Gut · doi:10.1136/gut.2007.120691 · Cited by 25 · cited 1×
“esophageal mucosal injury and the development of dysmotility [13,18,19].”
BackgroundBai, A., Ouyang, Q., & Hu, R. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-2857-5 · Cited by 23
(2007) · PubMed · Cited by 20
Hershcovici, T., Jha, L. K., Gadam, R., Cui, H., Gerson, L., Thomson, S., & Fass, R. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31824e139b · Cited by 18 · cited 3×
“There is also evidence that the increase in reflux esophagitis in type II diabetes occurs via elevated oxidative stress [54,55].”
BackgroundImpact of inflammation-metaplasia-adenocarcinoma sequence and prevention in surgical rat models
Miyashita, T., Shah, F. A., Miwa, K., Sasaki, S., Nishijima, K., Oyama, K., Ninomiya, I., Fushida, S., Fujimura, T., Hattori, T., et al. (2013) · Digestion · doi:10.1159/000343896 · Cited by 16 · cited 2×
“According to a recent study, gastric acid is a strong activator a number of autoprotective mechanisms, including proliferation and differentiation, as well as the production of anti-inflammatory cytokines, growth factors and endogenous antioxidants [4,11,12].”
BackgroundDevelopmental origins of colon smooth muscle dysfunction in IBS-like rats
Li, Q., Winston, J. H., & Sarna, S. K. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00160.2013 · Cited by 12 · cited 1×
“Indeed, several important advances have been made with respect to understanding the early biochemical and molecular mechanisms of ulceration and healing in other parts of the GI tract [12,14–16].”
BackgroundLangner, C., Schneider, N. I., Plieschnegger, W., Schmack, B., Bordel, H., Höfler, B., Eherer, A. J., Wolf, E., Rehak, P., & Vieth, M. (2014) · Histopathology · doi:10.1111/his.12367 · Cited by 11
(2008) · PubMed · Cited by 10
Self-citationP Selectins and immunological profiles in HCV and Schistosoma mansoniinduced chronic liver disease
Kamel, M. M., Fouad, S. A., & Basyoni, M. M. A. (2014) · BMC Gastroenterology · doi:10.1186/1471-230x-14-132 · Cited by 10
Cell/Tissue Injury and Cytoprotection/Organoprotection in the Gastrointestinal Tract
Filaretova, L. P., Takeuchi, K., & International Symposium on Cell Tissue Injury and Cytoprotection, O. F. O. G. T. 2. S. P. (2012) · Frontiers of gastrointestinal research · doi:10.1159/isbn.978-3-318-02184-4 · Cited by 8
[Oral and gastric diffuse neuroendocrine system: discussion questions of structure and function].
Zaiachkivs'ka, O. S., Mr, H., & Kovalyshyn, V. (2005) · PubMed · Cited by 5
Zayachkivska, О. (2012) · Frontiers of gastrointestinal research · doi:10.1159/000338434 · Cited by 2
Self-citationHrytsevych, N., Zayachkivska, О., & Yashchenko, А. М. (2013) · The FASEB Journal · doi:10.1096/fasebj.27.1_supplement.1169.2 · Cited by 2 · cited 3×
“We previously demonstrated increased production of nitric oxide metabolites and iNOS activity, as well as altered eicosanoid synthesis in experimental non-erosive esophagitis induced by experimental diabetes, hyperglycemia or restraint-stress in rats [17,23,24,57,58].”
BackgroundSelf-citationHydrogen sulfide protects from colitis: a possible role in stabilizing gut microbiota (898.3)
Motta, J., Flannigan, K. L., Agbor, T. A., Blackler, R. W., Workentine, M., Silva, G., Buret, A. G., & Wallace, J. L. (2014) · The FASEB Journal · doi:10.1096/fasebj.28.1_supplement.898.3 · Cited by 1
Self-citation
Research works printed but not linked: 4
- O Zayachkivska, 2009, Esophageal structural and functional reorganisation: role of endogenous defense mediators, Journal of Physiological Sciences, 59, 389
- VV Kozar, 2009, The state of the humoral component of immunity under conditions of metabolic syndrome with underlying hypoestrogenia and its farmacological correction. [in Ukrainian], Buk Med Herald, 13, 141
- OC Zayachkivska, 2006, Significance of NO-mediated mechanism in resistance of esophageal mucosa, Ukr Medical Almanac, 9, 48
- O Zayachkivska, 2010, Effect of proinflammatory cytokine-mediated mechanism of quality of gastrointestinal restitutio ad integrum, Annales Universitatis Mariae Curie-Skłodowska, 28, 211
Cited by
Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter
Wallace, J. L., & Wang, R. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4433 · Cited by 878
Self-citationMotta, J.-P., Flannigan, K. L., Agbor, T. A., Beatty, J. K., Blackler, R. W., Workentine, M. L., Da Silva, G. J., Wang, R., Buret, A. G., & Wallace, J. L. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000345 · Cited by 200
Self-citationH2S biosynthesis and catabolism: new insights from molecular studies
Rose, P., Moore, P. K., & Zhu, Y. Z. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2406-8 · Cited by 165
“Studies focused on delineating these molecular networks have revealed H2S to have important roles in cytoprotection [16–20], inflammation [21–24], vascular function [25–27], neurological systems [28], tissue repair and healing [29–34], apoptosis and the cell cycle [35, 36], mitochondrial function and energy metabolism…”
BackgroundFunctional and Molecular Insights of Hydrogen Sulfide Signaling and Protein Sulfhydration
Sen, N. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.12.015 · Cited by 164
Magierowski, M., Magierowska, K., Kwiecień, S., & Brzozowski, T. (2015) · Molecules · doi:10.3390/molecules20059099 · Cited by 155
“[131] have demonstrated that H2S serves as a protective factor against non-erosive esophagitis The protective effect of H2S against esophagitis and GERD in humans await further experimental and clinical studies.”
Background
Metadata
- Authors
- Zayachkivska, O., Havryluk, O., Hrycevych, N., Bula, N., Grushka, O., & Wallace, J. L.
- Affiliations
- Danylo Halytsky Lviv National Medical University (UA)
- University of Calgary (CA)
- Corresponding author
- Wallace, John L.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-10-21
- Volume
- 9
- Issue
- 10
- Pages
- e110688
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4204999
- OpenAlex
- W1977647501
- Cited by
- 34
- References
- 59
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 3 · 2019: 3 · 2018: 2 · 2017: 2 · 2016: 6 · 2015: 7 · 2014: 1
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Canadian Institutes of Health Research (12033, FRN-12033)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Sulfur Compounds in Biology
- Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Hydrogen's biological and therapeutic effects
- Keywords
- hydrogen sulfide, gastroesophageal reflux disease, esophageal mucosal protection, water immersion stress, H2S donors, IL-17, IL-10, esophageal inflammation, neutrophil infiltration, esophageal edema, Barrett's esophagus
- MeSH terms
- Animals, Disease Models, Animal, Esophagitis, Gastroesophageal Reflux, Humans, Hydrogen Sulfide, Interleukin-10, Cytoprotection, Interleukin-17, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.